Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1673.55
4.35 (0.26%)
< Home < Back

Sun Pharmaceutical Industries informs about press release

Date: 18-11-2022

Sun Pharmaceutical Industries has informed that its Press Release relating to US FDA approval for phenobarbital sodium powder for injection, which we shall be releasing after sending this letter.

The above information is a part of company’s filings submitted to BSE.